the Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-beta Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results from a Randomized, Double-blind, Placebo-controlled Phase Ii Trial : abstract Number: 3203
2015
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
14
Citations
NaN
KQI